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Variation of growth rate of a rat tumour during a light-dark cycle:
correlation with circadian fluctuations in tumour blood flow
K Hon, Q-H Zhang, H-C Li and S Saito
Department of Tumour Microcirculation, Institute ofDevelopment, Aging and Cancer, Tohoku Universitu, 4-1 Seiryomachi,
Aoba-ku, Sendai 980-77, Japan.
Summary To determine whether tumour growth is influenced by circadian variations in tumour tissue blood
flow, we measured changes in area doubling time of tumours (Sato lung carcinoma) within transparent
chambers and changes in tissue blood flow of rat subcutaneous tumour during a light-dark cycle. Rats were
subjected to an artificial light-dark cycle with light from 7 a.m. to 7 p.m. Tumour doubling times (TDTs)
dunrng the dark and the light spans were 33.5 ± 11.9 h (n = 38, 20 rats) and 70.6 ± 36.9 h (n = 39, 20 rats)
respectively. The former was significantly shorter than the latter (P<0.001). In addition, the larger the tumour
became, the longer was the TDT during the light span (P<0.05). Tumour tissue blood flow dunrng the night
(10 p.m.-4 a.m.) was approximately 1.5 times greater than that during the day (10 a.m.-4 p.m.). The time
dunrng which tumours actively grow and that during which tissue blood flow in tumours increases coincided.
These results strongly suggest that tumour tissue blood flow is a determining influence on tumour proliferative
activity and that tumour growth is influenced by circadian variations in tumour tissue blood flow.
Keyword: rat tumour; tumour blood flow; tumour growth; doubling time; circadian; microcirculation
The most prominent characteristics of malignant tumours
involve abnormalities in growth. Tumour growth seems to
depend largely on blood supply to tumour tissue, i.e. tumour
tissue blood flow, because solid tumours grow rapidly as
soon as tumours become vasculanised (Ide et al., 1939; Algire
et al., 1945; Eddy and Casarett, 1973; Folkman, 1974) and,
conversely, the tumour mass achieves a steady state at a
comparatively small size when tumours are prevented from
vascularising (Gimbrone et al., 1972). In addition, it has been
reported that small tumours, which grow more rapidly, have
comparatively high perfusion values (Vaupel et al., 1987;
Kallinowski et al., 1989; Hori et al., 1993a). Some researchers
have also found that both labelling and the mitotic index are
higher at regions adjacent to blood vessels where nutrients
are present in relatively high concentrations and decrease
with increasing distance from blood vessels (Tannock, 1968;
Brammer et al., 1979; Gabbert et al., 1982; Porschen et al.,
1994).
Recently we discovered that there are circadian fluctua-
tions in tissue blood flow of rat s.c. tumours and that the
tumour tissue blood flow reaches its greatest value at night
(Hori et al., 1992). If the tumour growth is closely associated
with increases and decreases in tumour tissue blood flow, rat
s.c. tumours should grow more actively during the night. To
date, however, there have been no data relating to this
matter.
The purpose of the present study was to confirm experi-
mentally that in vivo growth of tumours synchronises with
circadian fluctuations in tumour tissue blood flow. Thus, we
measured changes in tumour doubling time, as well as
changes in tumour tissue blood flow, during a light-dark
cycle.
Materials and methods
Rats and tumour
Male Donryu rats (Crj-Donryu; Nippon Charles-River,
Yokohama. Japan), weighing 200-220 g each, were used for
measurements of tumour doubling time and for measure-
ments of tumour tissue blood flow. They were caged singly in
an air-conditioned room at a temperature of 25± 1C, and
given food and water ad libitum. For 3 weeks before the
beginning of the measurement they were subjected to an
artificial light-dark cycle with light from 7 a.m. to 7 p.m.
The tumour used was Sato lung carcinoma (SLC), establish-
ed in 1964 by Drs R Sato and Y Shimosato (Shimosato and
Watanabe, 1967), and maintained in our laboratory by suc-
cessive s.c. transplantation. The growth characteristics of
SLC are as follows. This tumour has a 98% take rate when
about 2 x 106 cells are implanted subcutaneously. When the
tumour is implanted in transparent chambers, demarcation
between the edge of the growing tumour and normal tissue is
clear and therefore suitable for the present experiment. In the
s.c. tumours, however, there is great intra-tumour hetero-
geneity, and extensive necrosis commences at a comparatively
early stage of growth. The volume (V) of s.c. tumour is
calculated by the following formula:
V= (x/6) x d1 x d, x d3
where dl, d2 and d3 are the long axis, short axis and height of
the tumour nodule respectively.
Anaesthesia
For measurement of tumour tissue blood flow, rats were
anaesthetised with pentobarbital sodium (Nembutal; Abbott
Laboratories, North Chicago, IL, USA) (30 mg kg-' by i.m.
injection) and enflurane (Ethrane; Abbott Laboratories)
(0.8-1.0%) in the inhaled carrier gas at I Imin-'). The
concentration of enflurane was controlled by means of an
anaesthetic apparatus for small laboratory animals (Hori et
al., 1991). Body temperature was maintained during anaes-
thesia by placing the animal on a heated stage at 34°C. All-
experiments were performed in a controlled-temperature box
(24.5 ± 0.3C) fitted with a suction duct, and were completed
within half an hour. We have confirmed by vital microscopic
observation that there is little disturbance of microcirculation
under the anaesthetic conditions described above.
Vital microscopic observation ofthe developing tumour and
measurement of tumour size
Vital microscopic observation and photographic recording of
the developing tumours were carried out using a rat trans-
parent chamber. Details of the chamber design and surgical
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technique have been published elsewhere (Honr et al., 1990).
Briefly, circular pieces of skin on opposing surfaces of the
dorsal flap were dissected away. leaving a thin subcutaneous
membrane. The transparent chamber was then inserted into
the skin fold. A small fragment (approximately 0.1 mm3) of
solid tumour was implanted from a donor rat onto the tissue
within the chamber when the transparent chamber was
installed. The mean thickness of subcutaneous tissue within
the chamber was about 110 ILm. Observations and photo-
graphs were started 4-7 days after tumour implantation and
were terminated when the tumour overgrew the transparent
chamber completely and tracings of the tumour were no
longer possible.
The tumour was observed by transmitted light microscopy
(BHS-323; Olympus, Tokyo, Japan) and photographed on
instant film (FP-100C; Fuji Photo Film, Tokyo, Japan) at
two different times of the day, i.e. at 7 a.m. and 7 p.m. The
size of the tumours was expressed in terms of tumour area
rather than tumour volume because a piece of tumour tissue
implanted within the chamber grows in a sheet-like fashion.
After serial photographs were taken at a low magnification
(objective 2 x, ocular 10 x), individual prints were assemb-
led into a montage. A transparent vinyl sheet was placed
over the photomontage and the tumour was traced onto the
overlay, frequently observing the tumour within the trans-
parent chamber for reference. Tumour area was measured
using a cursor interfaced with a digitising tablet (WT-
4400SE, WACOM Corp., Saitama, Japan) to a personal
computer. The software used was an Area-Distance Calcula-
tion Program (WACOM).
Evaluation ofgrowtth of tumours
Growth of tumours was represented by tumour doubling
time (TDT). The tumour sizes within the transparent
chambers at 7 a.m. and at 7 p.m. were plotted in a
semilogarithmic diagram vs time, and TDT during the 12 h
light span was calculated assuming exponential growth.
Likewise, the TDT dunrng the 12 h dark span was determined
from measurements of tumour sizes at 7 p.m. and 7 a.m. The
relationships between TDT and the light-dark cycle and
between tumour size and TDT both in light and in dark were
analysed.
Measurement oftissue bloodflow in the identical region of
tumours
We began measuring tissue blood flow of s.c. tumours with
the hydrogen gas clearance technique (Aukland et al., 1964)
when the tumour volume reached approximately 3cm3 at
7-10 days after tumour implantation (about 2 x 106cells).
Details of the method for measurement have been published
in our previous reports (Suzuki et al., 1989; Hori et al.. 1991.
1993b). Briefly. tumour tissue blood flow was assessed by the
clearance of the inert hydrogen gas which had saturated the
tissue following the inhalation of 9% hydrogen in air (601
min-'); after the inhalation was stopped, the washout of
hydrogen was monitored. The half-life for hydrogen clear-
ance was derived from the exponential curve and the flow
value (in ml min-' 100 g-' tissue) was calculated from the
half-life.
In the present experiments, 18 tumour-bearing rats were
used and a wire-type hydrogen electrode (TT-940OIA; Uni-
que Medical, Tokyo, Japan). 2.5 cm in length. and a needle-
type reference electrode (THU-001; Unique Medical) were
inserted in each rat. In all measurements the depth of the
inserted hydrogen electrode was less than 10mm from the
surface of the tumour nodule. The reference electrode was
inserted into s.c. tissue in the caudal region. Surgical oper-
ation was not required for insertion of the needle-type
reference electrode. We have confirmed that the error of flow
values obtained from three replicate measurements for half
an hour was within 10%. Accordingly. one measurement was
made from each tumour during the day (10 a.m. -4 p.m.) and
one during the night (10 p.m.-4a.m.). To reduce the possi-
bility that the repeated measurement itself. i.e. the order of
measurement. would interfere with results, we randomly
started the measurement either during the daytime or at
night. After the measurement of tumour tissue blood flow
during the day or at night. the hydrogen electrodes were left
in the tumour until the next measurement 12 h later. The
electrode within the tumour did not slip away from the
inserted position under the influence of the animal's move-
ment.
Statistical analysis
All data are presented as means ± s.d. The non-parametric
Wilcoxon signed-rank test and Mann-Whitney U-test were
used for comparison of tumour tissue blood flow and TDT
between the light and dark periods. The correlations between
tumour size and TDT in both light and dark periods were
obtained by simple regression. P<0.05 was accepted as
sigmnficant.
Results
Growth oftumours during a light-dark cYcle
Figure I shows a typical example of an SLC tumour develop-
ing within a transparent chamber. The tumour was photo-
graphed every 12 h. The clear whiter area is the tumour.
Figure 2a shows a sequence of five transparent sheets of
tumour tracings from Figure 1, and Figure 2b shows changes
in TDT calculated from the area changes in Figure 2a. The
samples with the time scale of over 36 h (maximum 60 h) are
shown in Figure 3 (six rats). Tumours within the transparent
chamber grew more rapidly during the dark span than during
the light span. The mean TDTs during the dark and light
periods were 33.5 ± 11.9 h (n = 38, 20 rats) and 70.6 ± 36.9 h
(n = 39, 20 rats) respectively (Figure 4). The former was
significantly shorter than the latter (P<0.001). The relation-
ship between tumour size and TDT in both light and dark
spans is shown in Figure 5. There was a positive correlation
between tumour size and TDT (P<0.05), and the slopes of
the two regression lines were significantly different (P<0.05).
That is, the larger the tumour became, the longer was the
TDT during the light span (Figure 5a). During the dark
span, however, the TDT did not increase significantly even in
large tumours (Figure 5b). This result shows that in large s.c.
tumours the difference in tumour growth between the light
and dark periods is significant.
Changes in tissue bloodflow in the identical region oftumours
during a light-dark cvcle
Figure 6 shows an example of histology 48 h after insertion
of the electrode. The platinum electrode did not provoke a
tissue reaction during the experimental period. Circadian
variations in tissue blood flow in the identical region of SLC
tumours are shown in Figure 7. Tumour tissue blood flow
was 22.2 ± 10.8 (mean ± s.d.) during the time period from
10 a.m. to 4 pm. and 33.8 ± 15.8 ml min-' 100 g-' dunrng the
time period from 10 p.m. to 4 a.m. (n = 18, 18 rats). Tumour
tissue blood flow during the night was significantly higher
than that dunrng the day (P<0.001).
Discion
It has been generally believed that growth of a malignant
tumour is always active through any 24 h period. However,
the present results clearly demonstrate that tumour growth is
not constant, but varies even during a 24 h time period.
When our tracings of tumour contours within a transparent
chamber, obtained every 12 h. were put on top of each other,
it became clear that the area of tumour growth dunrng the
dark span was larger than that during the light span. The
growth rings are similar to those of trees growing in aTumou yi and blood flow
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Figwe I SLC tumour developing within a transparent chamber during the light-dark cycle. (a) 7 a.m. (day 0). (b) 7 p.m. (day 0).
(c) 7 a.m. (day 1). (d) 7 p.m. (day 1). (e) 7 a.m. (day 2). The clear whiter area is the tumour.TuowpwUu and blood fim
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temperate climate, which consist of two elements, early wood
and late wood, corresponding to growth during warmer and
cooler seasons. Early wood gives a vivid account of active
growth of trees. From this analogy and our previous report
(Honr et al., 1992) indicating that tissue blood flow in LY80
tumour implanted subcutaneously increases during the night,
we are convinced that tumour growth is strongly influenced
by the surroundings, in particular by changes in tumour
tissue blood flow.
Since, in previous experiments with LY80 tumours, tissues
showed little necrosis even in large tumours, we were able to
conclude that there are circadian variations in tumour tissue
blood flow (Hori et al., 1992), despite the fact that we did
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Fge 3 Circadian variations in TDT. Samples (six rats) from
which measurements were obtained over more than 36 h are
shown. 0, TDT during the 12 h light period; 0, TDT during the
12 h dark period. Tumour growth shows the circadian pattern for
all cases.
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Figwe 2 (a) Tracings of the five photographs in Figure I show-
ing tree-like ring growth. Dotted zone, tumour growth area dur-
ing the 12 h light period (7 a.m. -7pm.); white zone, tumour
growth area during the 12 h dark period (7 p.m.-7 a.m.). Note
that the tumour grows more actively during the 12 h dark span.
(b) Changes in TDT (tumour doubling time) during the light-
dark cycle calculated from area changes in a. 0, TDT during the
12 h light period; 0, TDT during the 12 h dark period. Note that
there is a clear circadian rhythm in tumour growth.
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Figwe 4 TDT during the 12 h light period (0) and during the
12 h dark period (0). The mean TDT was 33.5 + 11 9 h (n = 38,
20 rats) during the 12 h dark period and 70.6 ± 36.9 h (n = 39, 20
rats) during the 12 h light period. TDT was significantly shorter
in the dark than in the hght (P<0.001).
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Figure 5 The correlation between tumour size and TDT during the 12 h light period (a, 0) and during the 12 h dark period (b.
*). (a) ! = 48.106 log x + 29.602 (r = 0.411. P = 0.0269, n = 29). (b) ! = 10.797 log x + 21.279 (r = 0.405, P = 0.0359, n = 27). The
slopes of the two regression lines are significantly different (P<0.05). Note that the larger the tumour size became, the longer
became the TDT during the light penrod.
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Feigw 6 Histology around the inserted hydrogen electrode
(H&E staining. x 50). The SLC tumour was sampled 48 h fol-
lowing insertion of the electrode. Black part is the electrode. No
tissue reaction is observed around the electrode.
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not measure tissue blood flow in the identical region within a
tumour. Using those techniques, SLC tumour was not suit-
able for measurements of tumour tissue blood flow in that
study because of the existence of extensive necrosis. There-
fore, in the present study, we have developed a new techni-
que by which we can measure tissue blood flow in identical
regions of tumours twice a day during different light cycle
penods.
Like LY80, SLC also showed circadian variation of
tumour tissue blood flow. Tumour tissue blood flow during
the night was approximately 1.5 times greater than that
during the day. We also observed within the transparent
chamber that the area where tumour tissue blood flow is very
low or stopped transiently during the daytime increased with
tumour growth, but, in many cases, in these areas circulation
resumed at night (data not shown). Although the transparent
chamber system used for the present experiments is highly
artificial and the results may not accurately reflect blood flow
changes in three-dimensional solid tumours, we believe that
the circadian fluctuations in tumour tissue blood flow
observed within the transparent chamber are fundamentally
the same as those measured in solid tumours of the subcutis.
In fact, in large s.c. tumours of LY80, low-flow or no-flow
LF ( U.
6 12 18 0
light dme r
Time
Fge 7 Tissue blood flow in the identical region of SLC
tumours. 0, Tissue blood flow in the daytime (10 a.m.-4p.m.);
0, tissue blood flow in the nightime (10 p.m.-4a.m.) (n = 18, 18
rats). Tumour tissue blood flow increased significantly in the
nighttime (P<0.001).
areas became prominent in the daytime (Honr et al., 1992).
Two facts strongly suggest that a major determinant
influencing in vivo growth of tumour is tumour tissue blood
flow: (i) the time during which tumour growth becomes more
active coincides with the time during which tumour tissue
blood flow increases; and (ii) the larger the tumour becomes,
the slower the tumour grows during daytime.
Using an imaging bioluminescence method, Walenta et al.
(1992) showed that the energetic state of tumour tissues is
influenced by the blood supply situation in each region.
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Westin et al. (1993) suggested that nutrition-induced altera-
tions in tumour growth are, in part. explained by alterations
in the tumour content of energy phosphates, probably related
to a changed tumour tissue blood flow. Our conclusions are
consistent with these reports. That is. if sufficient nutrients
are supplied to tumour cells as a result of increases in tumour
tissue blood flow. the energetic state of the tumour cells
becomes high. leading to enhancement of tumour growth.
Conversely, if tumour tissue blood flow decreases. energy
metabolism is severely impaired by the nutritional deficiency.
leading to slower tumour growth.
In recent years. it has been reported that there are circa-
dian variations in the fraction of tumour cells engaged in
DNA synthesis in a 24 h period (Klevecz et al.. 1987; Smaa-
land et al.. 1993) and also that there is circadian variation in
tumour toxicity to anti-cancer drugs (Hrushesky. 1985;
Hrushesky and Bjarnason. 1993). Recently. we have also
demonstrated that the efficacy of chemotherapy for s.c. SLC
tumours is improved by administering anti-cancer drugs dur-
ing the night. during which time the increase in tumour tissue
blood flow reaches a plateau (data not shown). Therefore. we
speculate that circadian variations in DNA synthesis of
tumour cells and in tumour toxicity to anti-cancer drugs
might be correlated with circadian variations in tumour tis-
sue blood flow.
Strictly speaking. however. it is not yet clear from the
present studies alone why there are circadian variations in
tumour growth. Perhaps tumour tissue blood flow and
tumour growth are independently influenced by some kinds
of cytokines and growth factors which are released by
tumour cells. Further studies are necessary to reach a definite
conclusion regarding a direct causal relationship between
tumour tissue blood flow and tumour growth activity. How-
ever, since the relationship between circadian fluctuations in
tumour tissue blood flow and in tumour growth has also
been observed in another tumour cell line (Yoshida ascites
hepatoma AH109A) (data not shown), we believe that in vivo
growth of tumour is strongly dependent on tumour tissue
blood flow. Clinically ordinary solid tumours are usually
larger than rat tumours. Therefore. time-dependent varia-
tions in tumour doubling time in human malignancy might
be more prominent than that in rat tumours. although the
circadian pattern might be reversed in cancer patients since
rodents are nocturnal. If it is possible to determine the
circadian variations in tumour tissue blood flow and tumour
growth in cancer patients, the appropriate timing of various
cancer therapies could led to greater efficacy.
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